SAN MATEO, Calif.--(BUSINESS WIRE)--RapidAI, the global leader in AI-driven medical imaging analysis and coordinated care, has received FDA 510(k) clearance for Lumina 3D™ by RapidAI—an industry-first ...
Juniper Biosciences today announced a strategic licensing agreement with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the development of JBS-003 (18F-fluoromisonidazole, or FMISO). This ...
A study developed a new technique to accurately analyse the properties of cancer cells and the surrounding tissue at the level of individual cells. This innovation enables a more comprehensive ...
Hosted on MSN
New diagnostic breakthrough predicts which head and neck cancer patients can be cured with surgery alone
Researchers from the University of Turku and Turku University Hospital, Finland, led by Docent Sami Ventelä and Professor Jukka Westermarck, have developed a diagnostic tool that can revolutionize the ...
Surveillance incorporating the physical examination, imaging, and emerging molecular biomarkers is an essential part of care for head and neck cancer (HNC) survivors and allows for the detection of ...
Head and neck squamous cell carcinoma (HNSCC) remains a globally prevalent malignancy with high morbidity and mortality. Despite therapeutic advances, patient outcomes are hindered by tumor ...
Researchers developed a diagnostic test based on the LIMA1-alpha protein to distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone, without the need for ...
Squamous cell carcinoma of the head and neck area is among the ten most common types of cancer. Using a method based on machine learning, researchers at the University of Helsinki in collaboration ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results